★ INSERT COIN◆NOW PLAYING: VENTURES◆HIGH SCORE: $100M ARR◆★ NEW STAGE UNLOCKED: ABOUT ME◆PRESS START◆★ DEMO DAY 04:00:00◆
★ INSERT COIN◆NOW PLAYING: VENTURES◆HIGH SCORE: $100M ARR◆★ NEW STAGE UNLOCKED: ABOUT ME◆PRESS START◆★ DEMO DAY 04:00:00◆
◀ BACK TO FEED
NEWS★ LIFE SCIENCES / BIOTECHNOV 10, 2026

Neobe raises $6.8m to develop tumour-targeting bacteria

A cancer treatment cannot help if it struggles to reach the tumour.

Neobe raises $6.8m to develop tumour-targeting bacteria

A cancer treatment cannot help if it struggles to reach the tumour.

What happened

Neobe announced a $6.8m seed round led by ARC Ventures, with participants including Faber and Macmillan Ventures. Funding supports engineered bacteria intended to break down physical barriers that limit cancer drugs' access to solid tumours.

Why it matters

The approach aims to complement existing treatments by changing the environment around a tumour. It targets a different part of the problem from designing another drug to attack cancer cells.

The bigger picture

Development now needs to establish safety, delivery and clinical benefit. The financing provides resources to advance that work.